#United States #Los Angeles #Securities Fraud #Nano-X Imaging #NNOX

Investors Urged to Join Class Action Against Nano-X Imaging Ltd.

In a recent alert issued by Glancy Prongay Wolke & Rotter LLP, investors are reminded of an important deadline that may significantly affect their financial interests concerning Nano-X Imaging Ltd. (NASDAQ: NNOX). Stakeholders who suffered losses from their investments in the company between March 31, 2025, and April 17, 2026, should take note of the impending August 11, 2026 deadline for filing a motion to appoint a lead plaintiff in a class action lawsuit alleging securities fraud.

The law firm has specified that this class action move is aimed at individuals who purchased or acquired Nano-X securities during the class period. Investors should be aware that if they experienced a financial loss due to their investments in Nano-X, they may have legitimate grounds to seek restitution under federal securities laws.

What Led to the Lawsuit?

The trigger for this legal action was the company’s announcement on April 20, 2026, in which Nano-X reported substantial financial losses totaling $33.4 million for the fourth quarter of 2025. Notably, these losses were primarily attributed to a $17.5 million impairment charge associated with a restructuring of its Korean chip manufacturing facility. This announcement caused a significant drop in the company’s stock price, which fell by $0.69, or 24.4%, registering a closing price of $2.16 per share that day.

Beyond the immediate financial fallout, the complaint asserts that Nano-X's management made several materially false claims and failed to disclose serious adverse facts regarding the company’s business operations. Among the most critical allegations are claims that:

1. Misrepresentation of Efficiency Gains: Nano-X leadership allegedly exaggerated the efficiency gains purportedly achieved within its operations, creating an illusion of a favorable business climate.
2. Disconnect Between Production and Demand: The company is accused of failing to align its production capabilities with actual market demand for its products, leading to unforecasted operational complications.
3. Increased Operational Expenses: The operational misalignment reportedly resulted in rising expenses and cash burn, compounding financial instability.
4. Impending Structural Reforms: The rise in costs was expected to compel the company into disruptive remedial actions—entailing costs associated with restructuring and asset impairment.
5. Misleading Communications: Management's positive outlook concerning Nano-X's business operation and future prospects lacked substantial evidence and was materially misleading.

How to Participate in the Class Action

As the deadline approaches, investors who wish to join the class action are encouraged to act swiftly. Those interested in participating or wanting more information about joining the case should contact the law firm of Glancy Prongay Wolke & Rotter LLP. The firm is asking affected investors to provide their details, including mailing address, telephone number, and the quantity of shares purchased for further assistance.

It’s crucial for potential class members that they understand they do not need to take immediate action to be part of the class. Investors can choose to have legal representation or can opt to remain passive participants in this legal process.

For more information and updates on this case, investors can follow Glancy Prongay Wolke & Rotter LLP on their platforms or visit their official website. Their expertise in handling such matters could be essential for impacted stakeholders navigating this legal landscape.

As the August 11 deadline approaches, it becomes more important for those with unrecovered losses from their Nano-X investments to seek clarification on their options if they aim to recover monetary losses.

For questions or inquiries, investors can contact:

Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles, California 90067
Email: [email protected]
Phone: 310-201-9150, Toll-Free: 888-773-9224

Stay proactive and informed to safeguard your rights as an investor in the face of potential corporate misconduct.